- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the effects of orteronel, when administered with prednisone, on the QT/QTc interval in patients with metastatic castration-resistant prostate cancer (mCRPC)
Critère d'inclusion
- Metastatic Castration-resistant Prostate Cancer (mCRPC)